GLPG Galapagos NV Loading...

From GILD earnings calls
Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
20:30
May 07 ◎
Dietmar Berger Chief Medical Officer, Gilead Sciences, Inc. GILD Q1 FY26 call
Gilead's pending acquisition of Oral Medicines includes a licensing deal with Galapagos for gamgertamig, highlighting a deepening partnership.
GLPG
HIGH

About GLPG Analyst Coverage

Buzzberg tracks GLPG (Galapagos NV) across 1 sources. 0 bullish vs 0 bearish calls from 1 analysts. Sentiment: evenly split. 1 total trade idea tracked. Latest voices: Dietmar Berger.